Related references
Note: Only part of the references are listed.Mast Cells Differentiated in Synovial Fluid and Resident in Osteophytes Exalt the Inflammatory Pathology of Osteoarthritis
Priya Kulkarni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Therapeutic effect of targeting Substance P on the progression of osteoarthritis
Yoshiko Shirakawa et al.
MODERN RHEUMATOLOGY (2022)
Obesity, Inflammation, and Immune System in Osteoarthritis
Udhaya Nedunchezhiyan et al.
FRONTIERS IN IMMUNOLOGY (2022)
Synovial mast cells from knee and hip osteoarthritis: histological study and clinical correlations
L. Farinelli et al.
JOURNAL OF EXPERIMENTAL ORTHOPAEDICS (2022)
Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: data from the osteoarthritis initiative
Thanat Kanthawang et al.
SKELETAL RADIOLOGY (2021)
Coagulation factors induce human skin mast cell and basophil degranula-tion via activation of complement 5 and the C5a receptor
Yuhki Yanase et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Neuromedin U Suppresses Collagen-Induced Arthritis through ILC2-Th2 Activation
Yuanyuan Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Obesity-induced inflammation: The impact of the hematopoietic stem cell niche
Emily Bowers et al.
JCI INSIGHT (2021)
Possible Regulation of bFGF Expression by Mast Cells in Osteoarthritis Patients with Obesity: A Cross-Sectional Study
Ken Takata et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
Differential Synovial CGRP/RAMP1 Expression in Men and Women With Knee OsteoarthritisYoshihisa
Kentaro Uchida et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Increase in Tryptase and Its Role in the Synovial Membrane of Overweight and Obese Patients with Osteoarthritis of the Knee
Ken Takata et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Increase in mast cell marker expression in the synovium of obese patients with osteoarthritis of the knee
Kentaro Uchida et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Mast Cells in Early Rheumatoid Arthritis
Felice Rivellese et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Vascular endothelial growth factor expression and their action in the synovial membranes of patients with painful knee osteoarthritis
Shotaro Takano et al.
BMC MUSCULOSKELETAL DISORDERS (2018)
Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production
Felice Rivellese et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children
Wei Hu et al.
ACTA PAEDIATRICA (2018)
Neuronal regulation of type 2 innate lymphoid cells via neuromedin U
Vania Cardoso et al.
NATURE (2017)
Increase and regulation of synovial calcitonin gene-related peptide expression in patients with painful knee osteoarthritis
Shotaro Takano et al.
JOURNAL OF PAIN RESEARCH (2017)
Production of complement components by cells of the immune system
R. Lubbers et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Characterization of synovial mast cells in knee osteoarthritis: association with clinical parameters
B. J. E. de Lange-Brokaar et al.
OSTEOARTHRITIS AND CARTILAGE (2016)
Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission
Julio Ramirez et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Neuromedin U: A Multifunctional Neuropeptide with Pleiotropic Roles
Vanesa G. Martinez et al.
CLINICAL CHEMISTRY (2015)
Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
Troy Noordenbos et al.
ARTHRITIS AND RHEUMATISM (2012)
The neuropeptide neuromedin U promotes autoantibody-mediated arthritis
Sindhuja M. Rao et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Nmur1-/- mice are not protected from cutaneous inflammation
Susan J. Abbondanzo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Obesity and osteoarthritis in knee, hip and/or hand: An epidemiological study in the general population with 10 years follow-up
Margreth Grotle et al.
BMC MUSCULOSKELETAL DISORDERS (2008)
Molecular dissection of G protein preference using Gsα chimeras reveals novel ligand signaling of GPCRs
Shih-Han Hsu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia
M Moriyama et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock
M Moriyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells
M Moriyama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell
CA Oskeritzian et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice
TJ Kowalski et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway
R Hanada et al.
NATURE MEDICINE (2004)
Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1
EN Johnson et al.
JOURNAL OF IMMUNOLOGY (2004)
Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status
ES Graham et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Pro-nociceptive effects of neuromedin U in rat
XH Yu et al.
NEUROSCIENCE (2003)
Characterization of neuromedin U effects in canine smooth muscle
TD Westfall et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Identification of a novel neuromedin U receptor subtype expressed in the central nervous system
LX Shan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system
R Raddatz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U
JA Hedrick et al.
MOLECULAR PHARMACOLOGY (2000)
Identification and functional characterization of a novel subtype of neuromedin U receptor
M Hosoya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3
R Fujii et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3
PG Szekeres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of receptors for neuromedin U and its role in feeding
AD Howard et al.
NATURE (2000)
Share Paper
